Extrapyramidal syndrome presenting as dysphagia: a case report.
Extrapyramidal symptoms are well-documented complications of therapy with haloperidol, even when small doses are used. Dysphagia, though uncommon, can be quite debilitating and can mimic a paraneoplastic syndrome. It is important to always review the medications the patient is taking and consider them as etiological culprits in any new symptom complex. This report highlights a case of drug-induced dysphagia in a patient receiving haloperidol for obsessive nocturnal thoughts and auditory disturbances.
Gonzalez
Faustino
F
Hospice of Palm Beach County, Inc., West Beach, Florida 33407, USA. fagonzalez@hpbc.com
D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis; D003680:Deglutition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D004155:Diphenhydramine; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006212:Hallucinations / Q000188:drug therapy; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008539:Meigs Syndrome / Q000150:complications; D009730:Nursing Assessment; D010051:Ovarian Neoplasms / Q000150:complications; D010166:Palliative Care / Q000379:methods; D012893:Sleep Wake Disorders / Q000188:drug therapy
D014150:Antipsychotic Agents; D004155:Diphenhydramine; D006220:Haloperidol